ClinicalTrials.Veeva

Menu

Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor (LUNG-CANCER)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Lung Cancer Stage IV

Treatments

Other: Advanced lung cancer patients' group

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The distribution of demographic, clinical, radiological, pathological and molecular characteristics of lung cancer at the time of diagnosis, as well as preferential association between elements of those domains, have not been specifically studied in Italy. The aim of the present project is to assess, in a systematic fashion, the demographic, clinical, radiological, pathological and molecular characteristics of advanced lung cancer at the time of diagnosis in a large Italian cohort of consecutive patients referred to two tertiary referral centers.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >18 years
  • Suspicion of lung cancer based on imaging (CT and/or PET/CT)
  • Indication to a biopsy for diagnosis, staging and/or molecular profiling

Exclusion criteria

  • Inability or unwillingness to provide a written informed consent
  • ECOG performance status (>3) which makes a tissue diagnosis unfeasible
  • ASA 4 status
  • TNM Stage I-III

Trial contacts and locations

3

Loading...

Central trial contact

Rocco Trisolini, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems